Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medecine Sciences : M/S|May 24, 2022
[Integrins in cardiac fibrosis]Clément Delacroix, Jean-Sébastien Hulot
Clinical and Experimental Pharmacology & Physiology|June 29, 2023
Valproic acid reduces muscle susceptibility to contraction-induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophyDylan Moutachi, Mégane Lemaitre, Clément Delacroix, et al.
Plos One|April 18, 2022
The beneficial effect of chronic muscular exercise on muscle fragility is increased by Prox1 gene transfer in dystrophic mdx muscleAlexandra Monceau, Clément Delacroix, Mégane Lemaitre, et al.
The Journal of Physiology|June 10, 2020
Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouseArnaud Ferry, Julien Messéant, Ara Parlakian, et al.
Biochemical Pharmacology|October 5, 2025
Inhibition of integrin alpha V reduces inflammation and the transition to heart failure after pressure overloadClément Delacroix, Alexandra Achab Ali, Paul Alayrac, et al.
Scientific Reports|August 12, 2025
Left ventricle strain and T1 mapping evaluation in a mouse model with myocardial infarctionKhaoula Bouazizi, Thulaciga Yoganathan, Frank Kober, et al.
Circulation|December 9, 2022
Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial InfarctionNihar Masurkar, Marion Bouvet, Damien Logeart, et al.
Scientific Reports|July 11, 2020
Anti-integrin αv therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1+ stromal cellsMarion Bouvet, Olivier Claude, Maguelonne Roux, et al.
Pageof 1